Illustrative photo of CDC vaccine panel voting to limit hepatitis B newborn shots to high-risk infants, with Trump signing vaccination schedule review.
Illustrative photo of CDC vaccine panel voting to limit hepatitis B newborn shots to high-risk infants, with Trump signing vaccination schedule review.
Hoton da AI ya samar

CDC vaccine panel scales back hepatitis B birth-dose recommendation

Hoton da AI ya samar
An Binciki Gaskiya

The U.S. Centers for Disease Control and Prevention’s vaccine advisory committee has voted to end its longstanding recommendation that all newborns receive a hepatitis B shot at birth, instead limiting the guidance to infants at higher risk. President Donald Trump praised the move and signed a memorandum directing a broader review of the childhood vaccination schedule, signaling a major shift in U.S. vaccine policy.

In an 8-3 vote this week, the Advisory Committee on Immunization Practices (ACIP), the Centers for Disease Control and Prevention’s vaccine panel, voted to end its universal recommendation that all newborns receive a hepatitis B vaccine dose shortly after birth. The panel now recommends a birth dose only for infants whose mothers test positive for hepatitis B or whose infection status is unknown, while calling for individual decision-making between parents and clinicians when mothers have tested negative.

The change marks a significant departure from a policy dating back to 1991, under which nearly all U.S. infants received their first hepatitis B dose within 24 hours of delivery, followed by completion of a three-dose series in early childhood.

ACIP members also backed a new approach to the three-dose series. In a separate 6-4 vote, the panel recommended that some children could potentially forgo later doses if antibody testing after earlier shots shows sufficient protection, and urged that such testing be covered by insurance.

On Friday, President Donald Trump publicly endorsed the ACIP decision in a post on Truth Social, calling it “very good” and arguing that most newborns face little risk from hepatitis B, which is often spread through sexual contact or shared needles. In his post, cited by The Daily Wire, Trump wrote that the committee had made “a very good decision to END their Hepatitis B Vaccine Recommendation for babies, the vast majority of whom are at NO RISK of Hepatitis B, a disease that is mostly transmitted sexually, or through dirty needles.”

Trump also criticized the broader childhood immunization schedule, asserting that “The American Childhood Vaccine Schedule long required 72 ‘jabs,’ for perfectly healthy babies, far more than any other Country in the World, and far more than is necessary. In fact, it is ridiculous! Many parents and scientists have been questioning the efficacy of this ‘schedule,’ as have I!” according to his Truth Social statement reported by The Daily Wire.

The president said he had signed a presidential memorandum directing the Department of Health and Human Services (HHS) to “FAST TRACK” a comprehensive evaluation of childhood vaccine schedules used in other countries, with the goal of better aligning the U.S. schedule with what he called the “Gold Standard of Science and COMMON SENSE.” The order tasks HHS and the CDC with reviewing international practices while maintaining vaccine access, according to coverage by outlets including Politico.

Trump added that he was “fully confident Secretary Robert F. Kennedy, Jr., and the CDC, will get this done, quickly and correctly, for our Nation’s Children,” concluding the post with “MAHA!,” a slogan he has used in prior statements.

Under Health and Human Services Secretary Robert F. Kennedy Jr., the department has also moved to modify federal COVID-19 vaccine recommendations and to promote separate chickenpox vaccination for very young infants, while signaling openness to further reviews of vaccine safety, The Daily Wire reports.

The hepatitis B vote has drawn strong criticism from many public health and medical groups, which warn the shift could lead to more infant infections and undermine decades of progress achieved through universal newborn vaccination. Final adoption of the new recommendations will depend on action by the CDC’s acting director.

Abin da mutane ke faɗa

Reactions on X to the CDC ACIP panel's vote to end universal hepatitis B birth-dose recommendation are polarized. Vaccine skeptics and RFK Jr. supporters hail it as a victory for informed consent and safety, citing inadequate clinical trials, low risk to newborns from uninfected mothers, and Trump's praise alongside a broader schedule review. Public health advocates and doctors decry it as dangerous anti-science that risks resurging infections, chronic liver disease, and cancer, attributing the shift to RFK Jr.'s influence.

Labaran da ke da alaƙa

The Ministry of Health has urged parents and families to complete children's vaccination schedules before the 2026 school year begins, to prevent contagions in schools and homes. The National Vaccination Calendar recommends specific doses at ages 5 and 11. This call comes amid a rise in whooping cough cases in January 2026.

An Ruwaito ta hanyar AI

One of the world's leading medical journals, The Lancet, has published a sharp editorial rebuking Robert F. Kennedy Jr.'s tenure as U.S. Secretary of Health and Human Services after one year. The piece highlights controversial actions that it says have damaged public health efforts. It warns that the effects could take generations to undo.

A Biden-appointed federal judge in Oregon issued a verbal ruling Thursday blocking a Trump administration HHS declaration that deemed transgender medical procedures for minors unsafe and ineffective. The decision sides with Democratic attorneys general who sued over the December 2025 policy from HHS Secretary Robert F. Kennedy Jr.

An Ruwaito ta hanyar AI

Scientists have harvested antibodies from the blood of paediatricians to develop new preventative treatments for respiratory syncytial virus (RSV) and human metapneumovirus. These antibodies outperform existing therapies by up to 25 times and target a wider range of strains. The discovery stems from the natural immunity built by paediatricians through years of exposure to respiratory viruses.

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi